Clinical Trial Update: A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 clinical trial comparing LY900014 (Lyumjev) to insulin lispro (Humalog) in participants with Type 1 diabetes; the study is completed and results have be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Humalog (insulin lispro)
• Lyumjev (insulin lispro)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED | Results posted: 2024-09-03